Publication Name	World Journal of Clinical Cases
Manuscript ID	64117
Country	China

Received	2021-02-09 10:05
Peer-Review Started	2021-02-09 10:10
To Make the First Decision
Return for Revision	2021-02-28 17:55
Revised	2021-03-11 13:53
Second Decision	2021-04-25 11:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-25 13:02
Articles in Press	2021-04-25 13:02
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-06 23:12
Typeset the Manuscript	2021-05-31 11:44
Publish the Manuscript Online	2021-06-24 07:26

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	You-Zhe Gong, Xue-Mei Zhong and Ji-Zhen Zou
ORCID	Author(s) ORCID Number You-Zhe Gong http://orcid.org/0000-0002-8696-1325 Xue-Mei Zhong http://orcid.org/0000-0002-2171-5334 Ji-Zhen Zou http://orcid.org/0000-0002-6202-7319
Funding Agency and Grant Number
Corresponding Author	Xue-Mei Zhong, MD, Associate Professor, Chief Doctor, Gastroenterology Department, Capital Institute of Pediatrics, No.2 Yabao Road, Chaoyang District, Beijing 100020, China. zhongxuemei@shouer.com.cn
Key Words	Crohn’s disease; Glycogen storage disease type I; Treatment; Infliximab; Case report
Core Tip	Conventional treatment cannot alleviate symptoms of intestinal inflammation in glycogen storage disease type Ib (GSD-Ib). Although biological agents are effective for treating Crohn’s disease (CD), their application in the treatment of GSD-Ib with CD has been rarely reported. Infliximab was selected for this patient, it successfully alleviates the intestinal symptoms of the patient. For cases with poor outcome using the granulocyte colony-stimulating factor treatment, infliximab can be used for treatment.
Publish Date	2021-06-24 07:26
Citation	Gong YZ, Zhong XM, Zou JZ. Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report. World J Clin Cases 2021; 9(19): 5280-5286
URL	https://www.wjgnet.com/2307-8960/full/v9/i19/5280.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i19.5280

Full Article (PDF)	WJCC-9-5280.pdf
Full Article (Word)	WJCC-9-5280.docx
CARE Checklist–2016	64117-CARE-Checklist–2016-revision.jpg
Manuscript File	64117-Review-Filipodia-CL.docx
Answering Reviewers	64117-Answering reviewers.pdf
Audio Core Tip	64117-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	64117-Conflict-of-interest statement.pdf
Copyright License Agreement	64117-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	64117-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	64117-Language certificate.pdf
Peer-review Report	64117-Peer-review(s).pdf
Scientific Misconduct Check	64117-Bing-Wang JL-1.jpg
Scientific Misconduct Check	64117-Scientific misconduct check.pdf
Scientific Editor Work List	64117-Scientific editor work list.pdf